| Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | Frank Vinluan | 09/11/20 | National |
| Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 | Frank Vinluan | 08/10/20 | Boston |
| Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition | Frank Vinluan | 06/09/20 | New York |
| Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
| Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink | Frank Vinluan | 12/11/19 | National |
| Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More | Frank Vinluan | 11/08/19 | National |
| Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More | Frank Vinluan | 08/23/19 | National |
| Paratek Wins Two FDA Drug Approvals for Three Conditions in Same Day | Frank Vinluan | 10/03/18 | Boston |
| Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More | Frank Vinluan | 09/14/18 | National |
| Macrolide Pharma Raises $20M, Names Former Intarcia Exec Karande CEO | Frank Vinluan | 04/02/18 | Boston |
| Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More | Frank Vinluan | 02/02/18 | National |
| FDA Nixes Aradigm’s Inhaled Antibiotic, Asks for New Clinical Trial | Frank Vinluan | 01/29/18 | San Francisco |
| Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics | Frank Vinluan | 03/08/17 | Boston |
| Bayer Enlists Trana Discovery to Find New Fungicides for Field Crops | Frank Vinluan | 02/08/17 | Raleigh Durham |
| FDA Rejects Cempra Antibiotic, Asks for Another Clinical Trial | Frank Vinluan | 12/29/16 | Raleigh Durham |
| Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More | Alex Lash | 12/16/16 | National |
| AstraZeneca Spinout Entasis Snags $50M For Anti-Infective Treatments | David Holley | 04/04/16 | Boston |
| With New Data, Highs and Lows For Akebia, Flexion, Tetraphase | Ben Fidler | 09/08/15 | Boston |
| East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More | Ben Fidler | 03/06/15 | Boston |
| Third Rock’s New Revolution Looks to Squeeze More Drugs From Nature | Alex Lash | 02/04/15 | San Francisco |
| Roundup: New Funds at Wisegate, Savara, Besomebody, & Dallas startups | Angela Shah | 06/17/14 | Texas |
| East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More | Ben Fidler | 03/14/14 | Boston |
| East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More | Ben Fidler | 12/20/13 | Boston |
| San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More | Bruce V. Bigelow | 05/17/13 | San Diego |
| Brain Cells’ Antidepressant Disappoints in Clinical Study, Otonomy Hears the Sound of Money, Cognionics Wins Startup Competition, & More San Diego Life Sciences News | Denise Gellene | 06/17/10 | San Diego |
| Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News | Erin Kutz | 02/19/10 | Boston |
| Teva Takes Aim at Cubist Pharma’s Key Antibiotic Business | Ryan McBride | 02/10/09 | Boston |
| Targanta Faces New Challenges to Raise Cash After FDA Shoots Down the Firm’s Antibiotic | Ryan McBride | 12/10/08 | Boston |
